Regardless of internal variability of hyperplastic and cancerous samples (related to factors such as patients' age, progression of disease, treatment) we underlined significant elevated mRNA levels of α1A-AR and cav-1 in androgen-independent cancer compared to BPH. The gene discussed is CAV1; the disease is benign prostatic hyperplasia.